Khaled Al‐Hussein

675 total citations
17 papers, 563 citations indexed

About

Khaled Al‐Hussein is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Khaled Al‐Hussein has authored 17 papers receiving a total of 563 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Immunology and 4 papers in Oncology. Recurrent topics in Khaled Al‐Hussein's work include Lymphoma Diagnosis and Treatment (3 papers), T-cell and Retrovirus Studies (2 papers) and Curcumin's Biomedical Applications (2 papers). Khaled Al‐Hussein is often cited by papers focused on Lymphoma Diagnosis and Treatment (3 papers), T-cell and Retrovirus Studies (2 papers) and Curcumin's Biomedical Applications (2 papers). Khaled Al‐Hussein collaborates with scholars based in Saudi Arabia, United States and Netherlands. Khaled Al‐Hussein's co-authors include Pulicat Manogaran, Kishor Bhatia, Shahab Uddin, Marina Gutiérrez, Abdelilah Aboussekhra, Leonidas C. Platanias, Azhar R. Hussain, Ameera Gaafar, Azhar Hussain and Ibrahim Al‐Jammaz and has published in prestigious journals such as Blood, Cancer Research and Oncogene.

In The Last Decade

Khaled Al‐Hussein

17 papers receiving 548 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Khaled Al‐Hussein Saudi Arabia 11 301 157 123 112 85 17 563
Jack L. Arbiser United States 9 326 1.1× 121 0.8× 189 1.5× 33 0.3× 48 0.6× 10 645
Xiaohua Rong United States 14 354 1.2× 195 1.2× 88 0.7× 37 0.3× 44 0.5× 24 621
Darrell A. Robertson United States 11 228 0.8× 57 0.4× 129 1.0× 204 1.8× 35 0.4× 13 504
Ying-Chao Lin Taiwan 8 243 0.8× 72 0.5× 50 0.4× 138 1.2× 46 0.5× 13 722
Ganesan Ramamoorthi United States 18 431 1.4× 396 2.5× 92 0.7× 364 3.3× 35 0.4× 32 1.0k
Shiran Shapira Israel 15 306 1.0× 205 1.3× 18 0.1× 211 1.9× 72 0.8× 63 770
Dina Kazanov Israel 12 192 0.6× 174 1.1× 43 0.3× 114 1.0× 56 0.7× 40 451
Ruichuang Yang China 13 275 0.9× 101 0.6× 16 0.1× 91 0.8× 48 0.6× 21 586
G. C. O’Sullivan Ireland 11 183 0.6× 148 0.9× 80 0.7× 66 0.6× 17 0.2× 13 516

Countries citing papers authored by Khaled Al‐Hussein

Since Specialization
Citations

This map shows the geographic impact of Khaled Al‐Hussein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Khaled Al‐Hussein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Khaled Al‐Hussein more than expected).

Fields of papers citing papers by Khaled Al‐Hussein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Khaled Al‐Hussein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Khaled Al‐Hussein. The network helps show where Khaled Al‐Hussein may publish in the future.

Co-authorship network of co-authors of Khaled Al‐Hussein

This figure shows the co-authorship network connecting the top 25 collaborators of Khaled Al‐Hussein. A scholar is included among the top collaborators of Khaled Al‐Hussein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Khaled Al‐Hussein. Khaled Al‐Hussein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Gaafar, Ameera, et al.. (2012). Camel urine components display anti-cancer properties in vitro. Journal of Ethnopharmacology. 143(3). 819–825. 42 indexed citations
2.
Pyle, Robert, et al.. (2012). Monitoring immune responses in organ recipients by flow cytometry.. PubMed. 12(1). 32–41. 2 indexed citations
3.
Gaafar, Ameera, et al.. (2011). A study of KIR genes and HLA-C in Vogt-Koyanagi-Harada disease in Saudi Arabia.. PubMed. 17. 3523–8. 19 indexed citations
4.
Gaafar, Ameera, Khairia M. Youssef, Pulicat Manogaran, et al.. (2010). PAC, a novel curcumin analogue, has anti-breast cancer properties with higher efficiency on ER-negative cells. Breast Cancer Research and Treatment. 128(1). 97–107. 70 indexed citations
5.
Gaafar, Ameera, et al.. (2009). HLA-DRB1 among patients with Vogt-Koyanagi-Harada disease in Saudi Arabia.. PubMed. 15. 1876–80. 19 indexed citations
6.
Lehé, Cynthia, Hazem Ghebeh, Khaled Al‐Hussein, et al.. (2008). The Wilms' Tumor Antigen Is a Novel Target for Human CD4+ Regulatory T Cells: Implications for Immunotherapy. Cancer Research. 68(15). 6350–6359. 35 indexed citations
7.
Shinwari, Zakia, Pulicat Manogaran, Salman Alrokayan, Khaled Al‐Hussein, & Abdelilah Aboussekhra. (2007). Vincristine and lomustine induce apoptosis and p21WAF1 up-regulation in medulloblastoma and normal human epithelial and fibroblast cells. Journal of Neuro-Oncology. 87(2). 123–132. 18 indexed citations
8.
Thestrup‐Pedersen, Kristian, Ranjit S. Parhar, Kaida Wu, et al.. (2007). Skin-homing CD8+ T lymphocytes Show Preferential Growth in vitro and Suppress CD4+ T-cell Proliferation in Patients with Early Stages of Cutaneous T-cell Lymphoma. Acta Dermato Venereologica. 87(2). 118–126. 4 indexed citations
9.
Hussain, Azhar, Naif A. Al-Jomah, Abdul K. Siraj, et al.. (2006). Up-Regulation of Death Receptor 5 and Bax Translocation Is Necessary To Induce Apoptosis by Sanguinarine in Primary Effusion Lymphoma.. Blood. 108(11). 4615–4615. 1 indexed citations
10.
Uddin, Shahab, Azhar Hussain, Pulicat Manogaran, et al.. (2005). Curcumin suppresses growth and induces apoptosis in primary effusion lymphoma. Oncogene. 24(47). 7022–7030. 109 indexed citations
11.
Uddin, Shahab, Azhar R. Hussain, Khaled Al‐Hussein, et al.. (2005). Inhibition of Phosphatidylinositol 3′-Kinase/AKT Signaling Promotes Apoptosis of Primary Effusion Lymphoma Cells. Clinical Cancer Research. 11(8). 3102–3108. 98 indexed citations
12.
Almohanna, Mai, et al.. (2004). The tumor suppressor p16INK4a gene is a regulator of apoptosis induced by ultraviolet light and cisplatin. Oncogene. 23(1). 201–212. 56 indexed citations
13.
Uddin, Shahab, Azhar R. Hussain, Khaled Al‐Hussein, Leonidas C. Platanias, & Kishor Bhatia. (2004). Inhibition of phosphatidylinositol 3′-kinase induces preferentially killing of PTEN-null T leukemias through AKT pathway. Biochemical and Biophysical Research Communications. 320(3). 932–938. 64 indexed citations
14.
Hussain, Azhar R., Jean‐Pierre Doucet, Marina Gutiérrez, et al.. (2003). Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and Fas apoptosis in Burkitt's lymphomas with loss of multiple pro-apoptotic proteins.. PubMed. 88(2). 167–75. 11 indexed citations
15.
Al‐Hussein, Khaled, et al.. (2001). Isolation, purification and partial characterization of early pregnancy factor (EPF) from sera of pregnant women.. PubMed. 6(5). 209–14. 4 indexed citations
16.
Al‐Hussein, Khaled, et al.. (2001). Detection of xenoantibodies using a simple flow cytometric assay. Xenotransplantation. 8(3). 172–175. 5 indexed citations
17.
Al-Frayh, Abdulrahman, et al.. (1989). Inhalant Allergens in Patients with Allergic Rhinitis in Riyadh. Annals of Saudi Medicine. 9(4). 331–336. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026